Answers are grounded in this paper and cite their sources.
Patients who seek urologic care have recently reported a high degree of financial toxicity from prescription medications, including management for nephrolithiasis, urinary incontinence, and urological oncology. Estimating out-of-pocket costs can be challenging for urologists in the US because of variable insurance coverage, local pharmacy distributions, and complicated prescription pricing schemes. This article discusses resources that urologists can adopt into their practice and share with patients to help lower out-of-pocket spending for prescription medications.
No takes yet. Share an insight, caveat, or question.
Pockros et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: